The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Linking S. aureus Immune Evasion Mechanisms to Staphylococcal Vaccine Failures
Abstract
Vaccination arguably remains the only long-term strategy to limit the spread of S. aureus infections and its related antibiotic resistance. To date, however, all staphylococcal vaccines tested in clinical trials have failed. In this review, we propose that the failure of S. aureus vaccines is intricately linked to prior host exposure to S. aureus and the pathogen’s capacity to evade adaptive immune defenses. We suggest that non-protective immune imprints created by previous exposure to S. aureus are preferentially recalled by SA vaccines, and IL-10 induced by S. aureus plays a unique role in shaping these non-protective anti-staphylococcal immune responses. We discuss how S. aureus modifies the host immune landscape, which thereby necessitates alternative approaches to develop successful staphylococcal vaccines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The development of an effective S. aureus vaccine has been challenging due to a limited understanding of the immune mechanisms that confer protection against the pathogen [52].”
From Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms (2025) · cites this paper as [52]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kourtis, A. P., Hatfield, K., Baggs, J., Mu, Y., See, I., Epson, E., Nadle, J., Kainer, M. A., Dumyati, G., Petit, S., et al. (2019) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6809e1 · Cited by 701 · cited 1×
“SA is a leading cause of infections within healthcare facilities in the United States, with approximately 20,000 individuals succumbing to invasive diseases in 2017 [3].”
BackgroundIL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice
Cho, J. S., Pietras, E. M., Garcia, N. C., Ramos, R. I., Farzam, D. M., Monroe, H. R., Magorien, J. E., Blauvelt, A., Kolls, J. K., Cheung, A. L., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40891 · Cited by 658
CCR5 is a receptor for Staphylococcus aureus leukotoxin ED
Alonzo III, F., Kozhaya, L., Rawlings, S. A., Reyes-Robles, T., DuMont, A. L., Myszka, D. G., Landau, N. R., Unutmaz, D., & Torres, V. J. (2013) · Nature · doi:10.1038/nature11724 · Cited by 291
Where does a Staphylococcus aureus vaccine stand?
Fowler, V. G., & Proctor, R. A. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12570 · Cited by 241 · cited 1×
“It is notable that individuals with B-cell deficiency are generally not at higher risk of infection with SA compared to normal individuals [27].”
Background
Research works printed but not linked: 87
- Chatzakis, 2011, Infant colonization by Staphylococcus aureus: Role of maternal carriage, Eur. J. Clin. Microbiol. Infect. Dis., 30, 1111, 10.1007/s10096-011-1199-9 · DOI
- Sakr, A., Brégeon, F., Mège, J.L., Rolain, J.M., and Blin, O. (2018). Staphylococcus aureus Nasal Colonization: An Update on Mechanisms, Epidemiology, Risk Factors, and Subsequent Infections. Front. Microbiol., 9. · DOI · Paper page
- Wright, 1902, Notes on the Treatment of Furunculosis, Sycosis, and Acne by the Inoculation of a Staphylococcus aureus Vaccine, Lancet, 159, 874, 10.1016/S0140-6736(01)83603-5 · doi:10.1016/s0140-6736(01)83603-5
- Missiakas, 2016, Staphylococcus aureus vaccines: Deviating from the carol, J. Exp. Med., 213, 1645, 10.1084/jem.20160569 · DOI
- Clegg, 2021, Staphylococcus aureus Vaccine Research and Development: The Past, Present and Future, Including Novel Therapeutic Strategies, Front. Immunol., 12, 705360, 10.3389/fimmu.2021.705360 · DOI · Paper page
- Armentrout, E.I., Liu, G.Y., and Martins, G.A. (2020). T Cell Immunity and the Quest for Protective Vaccines against Staphylococcus aureus Infection. Microorganisms, 8. · DOI
- Miller, 2020, Development of a vaccine against Staphylococcus aureus invasive infections: Evidence based on human immunity, genetics and bacterial evasion mechanisms, FEMS Microbiol. Rev., 44, 123, 10.1093/femsre/fuz030 · DOI · Paper page
- Tsai, 2022, Non-protective immune imprint underlies failure of Staphylococcus aureus IsdB vaccine, Cell Host Microbe, 30, 1163, 10.1016/j.chom.2022.06.006 · DOI
- Howden, 2023, nature reviews microbiology Staphylococcus aureus host interactions and adaptation, Nat. Rev. Microbiol., 21, 380, 10.1038/s41579-023-00852-y · DOI · Paper page
- Goldmann, 2018, Staphylococcus aureus strategies to evade the host acquired immune response, Int. J. Med. Microbiol., 308, 625, 10.1016/j.ijmm.2017.09.013 · DOI
- Sharara, 2021, Decolonization of Staphylococcus aureus, Infect. Dis. Clin. N. Am., 35, 107, 10.1016/j.idc.2020.10.010 · DOI
- Vanegas, 2021, Staphylococcus aureus colonization increases the risk of bacteremia in hemodialysis patients: A molecular epidemiology approach with time-dependent analysis, Am. J. Infect. Control, 49, 215, 10.1016/j.ajic.2020.05.031 · DOI
- Tsai, 2022, Integrating complex host-pathogen immune environments into S. aureus vaccine studies, Cell Chem. Biol., 29, 730, 10.1016/j.chembiol.2022.04.003 · DOI
- Kobayashi, 2013, Staphylococcus aureus Protein A Promotes Immune Suppression, mBio, 4, e00764-13, 10.1128/mBio.00764-13 · DOI
- Forsgren, 1966, “Protein A” from S. aureus. I. Pseudo-immune reaction with human gamma-globulin, J. Immunol., 97, 822, 10.4049/jimmunol.97.6.822 · DOI · Paper page
- Goodyear, 2003, Death by a B cell superantigen: In vivo VH-targeted apoptotic supraclonal B cell deletion by a Staphylococcal Toxin, J. Exp. Med., 197, 1125, 10.1084/jem.20020552 · DOI · Paper page
- Viau, 2005, Staphylococcal Protein A Deletes B-1a and Marginal Zone B Lymphocytes Expressing Human Immunoglobulins: An Immune Evasion Mechanism, J. Immunol., 175, 7719, 10.4049/jimmunol.175.11.7719 · DOI
- Parcina, 2013, Pathogen-triggered activation of plasmacytoid dendritic cells induces IL-10-producing B cells in response to Staphylococcus aureus, J. Immunol., 190, 1591, 10.4049/jimmunol.1201222 · DOI
- Kim, 2010, Nontoxigenic protein A vaccine for methicillin-resistant Staphylococcus aureus infections in mice, J. Exp. Med., 207, 1863, 10.1084/jem.20092514 · DOI · Paper page
- Zhang, 1998, A second IgG-binding protein in Staphylococcus aureus, Microbiology, 144, 985, 10.1099/00221287-144-4-985 · DOI · Paper page
- Zhang, 1999, Staphylococcus aureus expresses a cell surface protein that binds both IgG and beta2-glycoprotein I, Microbiology, 145, 177, 10.1099/13500872-145-1-177 · DOI
- Tam, 2020, Targeting leukocidin-mediated immune evasion protects mice from Staphylococcus aureus bacteremia, J. Exp. Med., 217, e20190541, 10.1084/jem.20190541 · DOI
- Guerra, F.E., Borgogna, T.R., Patel, D.M., Sward, E.W., and Voyich, J.M. (2017). Epic Immune Battles of History: Neutrophils vs. Staphylococcus aureus. Front. Cell. Infect. Microbiol., 7. · DOI · Paper page
- Pidwill, 2020, The Role of Macrophages in Staphylococcus aureus Infection, Front. Immunol., 11, 620339, 10.3389/fimmu.2020.620339 · DOI · Paper page
- Miller, 2011, Immunity against Staphylococcus aureus cutaneous infections, Nat. Rev. Immunol., 11, 505, 10.1038/nri3010 · DOI · Paper page
- Brown, A.F., Murphy, A.G., Lalor, S.J., Leech, J.M., O’Keeffe, K.M., Mac Aogáin, M., O’Halloran, D.P., Lacey, K.A., Tavakol, M., and Hearnden, C.H. (2015). Memory Th1 Cells Are Protective in Invasive Staphylococcus aureus Infection. PLOS Pathog., 11. · DOI · Paper page
- Paterson, M.J., Caldera, J.R., Nguyen, C., Sharma, P., Castro, A.M., Kolar, S.L., Tsai, C.M., Limon, J.J., Becker, C.A., and Martins, G.A. (2020). Harnessing antifungal immunity in pursuit of a Staphylococcus aureus vaccine strategy. PLOS Pathog., 16. · DOI
- Dillen, 2018, Clonally expanded γδ T cells protect against Staphylococcus aureus skin reinfection, J. Clin. Investig., 128, 1026, 10.1172/JCI96481 · DOI
- Thammavongsa, 2015, Staphylococcal manipulation of host immune responses, Nat. Rev. Microbiol., 13, 529, 10.1038/nrmicro3521 · DOI · Paper page
- Xu, S.X., and McCormick, J.K. (2012). Staphylococcal superantigens in colonization and disease. Front. Cell. Infect. Microbiol., 2. · DOI · Paper page
- Berends, 2019, Staphylococcus aureus Impairs the Function of and Kills Human Dendritic Cells via the LukAB Toxin, mBio, 10, e01918-18, 10.1128/mBio.01918-18 · DOI
- Richardson, 2019, PSM Peptides From Community-Associated Methicillin-Resistant Staphylococcus aureus Impair the Adaptive Immune Response via Modulation of Dendritic Cell Subsets In Vivo, Front. Immunol., 10, 995, 10.3389/fimmu.2019.00995 · DOI
- Spaan, 2017, Leukocidins: Staphylococcal bi-component pore-forming toxins find their receptors, Nat. Rev. Microbiol., 15, 435, 10.1038/nrmicro.2017.27 · DOI · Paper page
- Schreiner, 2013, Staphylococcus aureus phenol-soluble modulin peptides modulate dendritic cell functions and increase in vitro priming of regulatory T cells, J. Immunol., 190, 3417, 10.4049/jimmunol.1202563 · DOI
- Mondal, S., Martinson, J.A., Ghosh, S., Watson, R., and Pahan, K. (2012). Protection of Tregs, Suppression of Th1 and Th17 Cells, and Amelioration of Experimental Allergic Encephalomyelitis by a Physically-Modified Saline. PLoS ONE, 7. · DOI
- Lee, 2020, Staphylococcus aureus toxin suppresses antigen-specific T cell responses J, Clin. Investig., 130, 1122, 10.1172/JCI130728 · DOI
- Mellergaard, 2023, Clinical Staphylococcus aureus inhibits human T-cell activity through interaction with the PD-1 receptor, mBio, 14, e1349-23, 10.1128/mbio.01349-23 · DOI
- Yao, 2009, PD-1 on dendritic cells impedes innate immunity against bacterial infection, Blood, 113, 5811, 10.1182/blood-2009-02-203141 · DOI · Paper page
- Triantafyllou, 2021, PD-1 blockade improves Kupffer cell bacterial clearance in acute liver injury, J. Clin. Investig., 131, e140196, 10.1172/JCI140196 · DOI
- Jurado, 2008, Programmed death (PD)-1:PD-ligand 1/PD-ligand 2 pathway inhibits T cell effector functions during human tuberculosis, J. Immunol., 181, 116, 10.4049/jimmunol.181.1.116 · DOI · Paper page
- Lee, 2002, The Staphylococcus aureus Map protein is an immunomodulator that interferes with T cell-mediated responses, J. Clin. Investig., 110, 1461, 10.1172/JCI0216318 · DOI
- Das, 2021, Basophil-derived IL-4 promotes cutaneous Staphylococcus aureus infection, JCI Insight, 6, e149953, 10.1172/jci.insight.149953 · DOI
- Sanchez, 2017, O-Acetylation of Peptidoglycan Limits Helper T Cell Priming and Permits Staphylococcus aureus Reinfection, Cell Host Microbe, 22, 543, 10.1016/j.chom.2017.08.008 · DOI
- Kak, 2023, IL-10 production by granulocytes promotes Staphylococcus aureus craniotomy infection, J. Neuroinflamm., 20, 114, 10.1186/s12974-023-02798-7 · DOI
- Frodermann, 2011, A Modulatory Interleukin-10 Response to Staphylococcal Peptidoglycan Prevents Th1/Th17 Adaptive Immunity to Staphylococcus aureus, J. Infect. Dis., 204, 253, 10.1093/infdis/jir276 · DOI
- Wang, 2000, Peptidoglycan and Lipoteichoic Acid from Staphylococcus aureus Induce Tumor Necrosis Factor Alpha, Interleukin 6 (IL-6), and IL-10 Production in Both T Cells and Monocytes in a Human Whole Blood Model, Infect. Immun., 68, 3965, 10.1128/IAI.68.7.3965-3970.2000 · DOI · Paper page
- Leech, 2017, IL-10 Plays Opposing Roles during Staphylococcus aureus Systemic and Localized Infections, J. Immunol., 198, 2352, 10.4049/jimmunol.1601018 · DOI
- Kelly, A.M., Leech, J.M., Doyle, S.L., and McLoughlin, R.M. (2022). Staphylococcus aureus-induced immunosuppression mediated by IL-10 and IL-27 facilitates nasal colonisation. PLoS Pathog., 18. · DOI
- Saraiva, 2020, Biology and therapeutic potential of interleukin-10, J. Exp. Med., 217, e20190418, 10.1084/jem.20190418 · DOI · Paper page
- Schultz, 2016, Opposing roles of IL-10 in acute bacterial infection, Cytokine Growth Factor Rev., 32, 17, 10.1016/j.cytogfr.2016.07.003 · DOI
- Redford, 2017, T Cell–Derived IL-10 Impairs Host Resistance to Mycobacterium tuberculosis Infection, J. Immunol., 199, 613, 10.4049/jimmunol.1601340 · DOI
- Pitt, 2012, Blockade of IL-10 signaling during bacillus Calmette-Guérin vaccination enhances and sustains Th1, Th17, and innate lymphoid IFN-γ and IL-17 responses and increases protection to Mycobacterium tuberculosis infection, J. Immunol., 189, 4079, 10.4049/jimmunol.1201061 · DOI · Paper page
- Ross, 2004, Adenylate cyclase toxin from Bordetella pertussis synergizes with lipopolysaccharide to promote innate interleukin-10 production and enhances the induction of Th2 and regulatory T cells, Infect. Immun., 72, 1568, 10.1128/IAI.72.3.1568-1579.2004 · DOI
- McGuirk, 2002, Pathogen-specific T Regulatory 1 Cells Induced in the Respiratory Tract by a Bacterial Molecule that Stimulates Interleukin 10 Production by Dendritic Cells: A Novel Strategy for Evasion of Protective T Helper Type 1 Responses by Bordetella pertussis, J. Exp. Med., 195, 221, 10.1084/jem.20011288 · DOI · Paper page
- Ng, 2013, Regulation of adaptive immunity; the role of interleukin-10, Front. Immunol., 4, 129, 10.3389/fimmu.2013.00129 · DOI · Paper page
- Heim, 2020, Lactate production by Staphylococcus aureus biofilm inhibits HDAC11 to reprogramme the host immune response during persistent infection, Nat. Microbiol., 5, 1271, 10.1038/s41564-020-0756-3 · DOI · Paper page
- Gresham, 2000, Survival of Staphylococcus aureus inside neutrophils contributes to infection, J. Immunol., 164, 3713, 10.4049/jimmunol.164.7.3713 · DOI · Paper page
- Wilk, 2015, Manipulation of Autophagy in Phagocytes Facilitates Staphylococcus aureus Bloodstream Infection, Infect. Immun., 83, 3445, 10.1128/IAI.00358-15 · DOI
- Donkor, E.S., Kotey, F.C.N., Dayie, N., Duodu, S., Tetteh-Quarcoo, P.B., Osei, M.M., and Tette, E.M.A. (2019). Colonization of HIV-Infected Children with Methicillin-Resistant Staphylococcus aureus. Pathogens, 8. · DOI
- Popovich, 2013, Community-Associated Methicillin-Resistant Staphylococcus aureus Colonization Burden in HIV-Infected Patients, Clin. Infect. Dis., 56, 1067, 10.1093/cid/cit010 · DOI
- Brenchley, 2008, Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections, Blood, 112, 2826, 10.1182/blood-2008-05-159301 · DOI · Paper page
- Khaitan, 2010, Susceptibility of human Th17 cells to human immunodeficiency virus and their perturbation during infection, J. Infect. Dis., 201, 843, 10.1086/651021 · DOI · Paper page
- Fernandez Plaza, T., Dekaban, G., and Madrenas, J. (2012). Role of IL-10 in the Immune Response to Staphylococcus aureus Nasal Carriage. [Master’s Thesis, Western University].
- Uebele, 2020, Staphylococcus aureus Protein A Induces Human Regulatory T Cells Through Interaction With Antigen-Presenting Cells, Front. Immunol., 11, 581713, 10.3389/fimmu.2020.581713 · DOI
- Hendriks, 2021, Staphylococcus aureus-Specific Tissue-Resident Memory CD4+ T Cells Are Abundant in Healthy Human Skin, Front. Immunol., 12, 642711, 10.3389/fimmu.2021.642711 · DOI
- Caldera, 2024, The characteristics of pre-existing humoral imprint determine efficacy of S. aureus vaccines and support alternative vaccine approaches, Cell Rep. Med., 5, 101360, 10.1016/j.xcrm.2023.101360 · DOI
- Meyer, 2021, A Comprehensive View on the Human Antibody Repertoire Against Staphylococcus aureus Antigens in the General Population, Front. Immunol., 12, 651619, 10.3389/fimmu.2021.651619 · DOI
- Wu, 2018, Prevalence of IgG and Neutralizing Antibodies against Staphylococcus aureus Alpha-Toxin in Healthy Human Subjects and Diverse Patient Populations, Infect. Immun., 86, e00671-17, 10.1128/IAI.00671-17 · DOI
- Radke, 2018, Hierarchy of human IgG recognition within the Staphylococcus aureus immunome, Sci. Rep., 8, 13296, 10.1038/s41598-018-31424-3 · DOI
- Francis, 1960, On the doctrine of original antigenic sin, Proc. Am. Philos. Soc., 104, 572
- Fowler, 2013, Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: A randomized trial, JAMA, 309, 1368, 10.1001/jama.2013.3010 · DOI · Paper page
- Francois, 2021, Efficacy and safety of suvratoxumab for prevention of Staphylococcus aureus ventilator-associated pneumonia (SAATELLITE): A multicentre, randomised, double-blind, placebo-controlled, parallel-group, phase 2 pilot trial, Lancet Infect. Dis., 21, 1313, 10.1016/S1473-3099(20)30995-6 · DOI
- Weems, 2006, Phase II, randomized, double-blind, multicenter study comparing the safety and pharmacokinetics of tefibazumab to placebo for treatment of Staphylococcus aureus bacteremia, Antimicrob. Agents Chemother., 50, 2751, 10.1128/AAC.00096-06 · DOI
- Teymournejad, 2023, Toxin expression during Staphylococcus aureus infection imprints host immunity to inhibit vaccine efficacy, NPJ Vaccines, 8, 3, 10.1038/s41541-022-00598-3 · DOI
- Hajam, I.A., Tsai, C.M., Caldera, J.R., Gonzalez, C., and Liu, G.Y. (2023, January 29–30). IL-10 production by a pathogen-specific CD4+T cell mediates failure of Staphylococcus aureus vaccines. Proceedings of the Staphylococcal Diseases, Gordon Conference, Waterville Valley, NH, USA.
- Ferreira, 2021, Early IL-10 promotes vasculature-associated CD4+ T cells unable to control Mycobacterium tuberculosis infection, JCI Insight, 6, e150060, 10.1172/jci.insight.150060 · DOI
- Smith, 2018, Interleukin-10 Directly Inhibits CD8+ T Cell Function by Enhancing N-Glycan Branching to Decrease Antigen Sensitivity, Immunity, 48, 299, 10.1016/j.immuni.2018.01.006 · DOI · Paper page
- Cao, 2021, Cytokines in the Immune Microenvironment Change the Glycosylation of IgG by Regulating Intracellular Glycosyltransferases, Front. Immunol., 12, 724379, 10.3389/fimmu.2021.724379 · DOI
- Bartsch, 2020, IgG Fc sialylation is regulated during the germinal center reaction following immunization with different adjuvants, J. Allergy Clin. Immunol., 146, 652, 10.1016/j.jaci.2020.04.059 · DOI
- Keener, 2017, Staphylococcus aureus Protein A Disrupts Immunity Mediated by Long-Lived Plasma Cells, J. Immunol., 198, 1263, 10.4049/jimmunol.1600093 · DOI
- Fiege, 2021, Mice with diverse microbial exposure histories as a model for preclinical vaccine testing, Cell Host Microbe, 29, 1815, 10.1016/j.chom.2021.10.001 · DOI
- Tseng, C.W., Biancotti, J.C., Berg, B.L., Gate, D., Kolar, S.L., Muller, S., Rodriguez, M.D., Rezai-Zadeh, K., Fan, X., and Beenhouwer, D.O. (2015). Increased Susceptibility of Humanized NSG Mice to Panton-Valentine Leukocidin and Staphylococcus aureus Skin Infection. PLoS Pathog., 11. · DOI
- Prince, 2017, Humanized Mice Exhibit Increased Susceptibility to Staphylococcus aureus Pneumonia, J. Infect. Dis., 215, 1386
- Redi, 2018, Staphylococcus aureus vaccine preclinical and clinical development: Current state of the art, New Microbiol., 41, 208
- Dadaglio, 2020, IL-17 suppresses the therapeutic activity of cancer vaccines through the inhibition of CD8+ T-cell responses, Oncoimmunology, 9, 1758606, 10.1080/2162402X.2020.1758606 · DOI
- Sogi, 2018, STING-Activating Adjuvants Elicit a Th17 Immune Response and Protect against Mycobacterium tuberculosis Infection, Cell Rep., 23, 1435, 10.1016/j.celrep.2018.04.003 · DOI
- Tsai, 2021, Adoptive Transfer of Serum Samples from Children with Invasive Staphylococcal Infection and Protection Against Staphylococcus aureus Sepsis, J. Infect. Dis., 223, 1222, 10.1093/infdis/jiaa482 · DOI
Cited by
Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms
Touaitia, R., Mairi, A., Ibrahim, N. A., Basher, N. S., Idres, T., & Touati, A. (2025) · Antibiotics · doi:10.3390/antibiotics14050470 · Cited by 273
Metadata
- Authors
- Hajam, I. A., & Liu, G. Y.
- Venue
- Antibiotics
- Publisher
- MDPI AG
- Published
- 2024-04-30
- Volume
- 13
- Issue
- 5
- Pages
- 410
- ISSN
- 2079-6382
- Cited by
- 20
- References
- 4
- Language
- en
- Funders
- National Institute of Health funding agency (R01AI179098, R01AI181321, R01AI144694)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Linking S. aureus Immune Evasion Mechanisms to Staphylococcal Vaccine Failures. https://app.cochat.ai/papers/10.3390/antibiotics13050410
- The paper
- Hajam, I. A., & Liu, G. Y. (2024). Linking S. aureus Immune Evasion Mechanisms to Staphylococcal Vaccine Failures. Antibiotics. https://doi.org/10.3390/antibiotics13050410
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.